Bd collaborates with u.s. government on development of covid-19 combination diagnostic tests

Franklin lakes, n.j., oct. 28, 2021 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced the formation of a strategic, public-private partnership with the biomedical advanced research and development authority (barda), part of the u.s. health and human services office of the assistant secretary for preparedness and response to support the development of a range of covid-19 combination diagnostic tests for core laboratories, hospitals and at the point of care.
BDX Ratings Summary
BDX Quant Ranking